Arvest Bank Trust Division Reduces Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Arvest Bank Trust Division lessened its position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 24.3% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 1,493 shares of the healthcare conglomerate's stock after selling 480 shares during the period. Arvest Bank Trust Division's holdings in UnitedHealth Group were worth $755,000 as of its most recent SEC filing.

Several other hedge funds have also recently modified their holdings of the business. Howard Capital Management Group LLC purchased a new stake in shares of UnitedHealth Group during the third quarter worth about $341,000. Principal Financial Group Inc. increased its holdings in shares of UnitedHealth Group by 11.3% in the 3rd quarter. Principal Financial Group Inc. now owns 1,778,636 shares of the healthcare conglomerate's stock worth $1,039,933,000 after buying an additional 180,479 shares during the last quarter. M&T Bank Corp lifted its holdings in shares of UnitedHealth Group by 13.4% in the 3rd quarter. M&T Bank Corp now owns 220,590 shares of the healthcare conglomerate's stock worth $128,975,000 after acquiring an additional 26,074 shares during the last quarter. McIlrath & Eck LLC boosted its holdings in UnitedHealth Group by 8.2% during the 3rd quarter. McIlrath & Eck LLC now owns 635 shares of the healthcare conglomerate's stock valued at $371,000 after acquiring an additional 48 shares during the period. Finally, SOA Wealth Advisors LLC. boosted its stake in UnitedHealth Group by 3.7% in the third quarter. SOA Wealth Advisors LLC. now owns 1,275 shares of the healthcare conglomerate's stock valued at $746,000 after acquiring an additional 46 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company's stock.

UnitedHealth Group Price Performance

Shares of NYSE:UNH traded down $128.94 during midday trading on Friday, hitting $456.10. The company had a trading volume of 29,048,929 shares, compared to its average volume of 4,373,443. UnitedHealth Group Incorporated has a twelve month low of $438.50 and a twelve month high of $630.73. The stock has a market cap of $417.20 billion, a price-to-earnings ratio of 29.43, a price-to-earnings-growth ratio of 1.37 and a beta of 0.61. The business's 50-day simple moving average is $512.95 and its 200-day simple moving average is $540.65. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.29 by ($0.09). The business had revenue of $109.58 billion for the quarter, compared to analyst estimates of $111.56 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. During the same period last year, the business earned $6.91 EPS. On average, research analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were paid a $2.10 dividend. The ex-dividend date was Monday, March 10th. This represents a $8.40 annualized dividend and a dividend yield of 1.84%. UnitedHealth Group's dividend payout ratio (DPR) is 54.19%.

Wall Street Analyst Weigh In

A number of research firms have issued reports on UNH. Truist Financial raised their price target on shares of UnitedHealth Group from $610.00 to $660.00 and gave the stock a "buy" rating in a report on Friday, April 11th. StockNews.com upgraded UnitedHealth Group from a "hold" rating to a "buy" rating in a research note on Thursday, January 23rd. Erste Group Bank upgraded shares of UnitedHealth Group to a "strong-buy" rating in a research note on Wednesday. Mizuho raised their target price on shares of UnitedHealth Group from $600.00 to $650.00 and gave the stock an "outperform" rating in a report on Wednesday, April 9th. Finally, Wells Fargo & Company reduced their price objective on UnitedHealth Group from $694.00 to $660.00 and set an "overweight" rating for the company in a research note on Tuesday, January 28th. Twenty-one equities research analysts have rated the stock with a buy rating and three have assigned a strong buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Buy" and a consensus price target of $632.85.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.